期刊文献+

胃肠道间质瘤的螺旋CT诊断及临床应用 被引量:15

Spiral CT diagnosis of gastrointestinal stromal tumors
原文传递
导出
摘要 目的分析胃肠道间质瘤(GIST)的螺旋CT表现及其在临床治疗方面的应用价值。方法对32例经手术病理证实的GIST患者的螺旋CT影像资料及临床资料进行回顾性分析。结果本组GIST中位于食管1例,胃22例,结肠系膜1例,小肠6例及结肠2例;良性4例,恶性28例;免疫组化染色CD117阳性表达率为75%,CD34阳性表达率为81%;病变多为外生型56%,良性病灶最大径平均为4.75cm,而恶性病变最大径平均为6.78cm。结论螺旋CT能够为GIST的定位、定性诊断提供重要的参考依据,但对GIST的定性诊断仍需要免疫病理来确定。 Objective To evaluate spiral CT diagnosis of gastrointestinal stromal tumors (GIST). Methods The CT findings and clinicopathological data of 32 GIST cases were retrospectively analyzed. Results Of the 32 GIST cases, 1 located in the esophagus, 22 in the stomach, 1 in the mesentery, 6 in the small intestine and 2 in the colon. There were 4 benign and 28 malignant cases. Expression of CD117 and CD34 was 75% and 81% respectively. The lesions were exogenous in 56% cases. The average size of the benign and malignant masses was 4.75 cm and 6.78 cm respectively. Conclusions Spiral CT could provide important information for the diagnosis and localization of GIST, but the final diagnosis still relies on oathology.
作者 李葆青
出处 《中华普通外科杂志》 CSCD 北大核心 2008年第6期419-421,共3页 Chinese Journal of General Surgery
关键词 胃肠道间质肿瘤 体层摄影术 X线计算机 螺旋CT诊断 Gastrointestinal tract stromal tumors Tomography, X-ray computed
  • 相关文献

参考文献7

  • 1Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science, 1998,279:577-580.
  • 2Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, et al. CD 117 : a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol, 1998,11:728-734.
  • 3杨春康,许东坡,黄永健,戴起宝.胃间质瘤临床分析[J].中国普通外科杂志,2002,11(4):218-219. 被引量:14
  • 4Urbanczyk K, Limon J, Korobowicz E, et al. Gastrointestinal stromal tumors:a multicenter experience. Pol J Pathol,2005,56: 51-61.
  • 5秦新裕,刘凤林.胃肠道间质瘤的研究进展与展望[J].中华普通外科杂志,2007,22(8):561-563. 被引量:34
  • 6Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol,2002,33:459- 465.
  • 7Eiseberg BL, Judson I. Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy. Ann Surg Oncol, 2004,11:465- 475.

二级参考文献8

  • 1詹文华,王鹏志,邵永孚,伍晓汀,顾晋,李荣,万德森,丁克峰,师英强,于吉人,卢辉山,邹小明,毕建威,孙益红,陆云飞,陈道达,张信华.伊马替尼术后辅助治疗胃肠间质瘤的多中心前瞻性临床试验中期报告[J].中华胃肠外科杂志,2006,9(5):383-387. 被引量:85
  • 2金行藻.胃肠道间质瘤[J].诊断病理学杂志,1996,3(2):108-110. 被引量:25
  • 3Fletcher CD, Berman J J, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol, 2002,33 : 459- 465.
  • 4Miettinen M, Makhlouf H, Lasota J, et al. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 casesbefore imatinib with long-term follow-up. Am J Surg Pathol, 2006, 30 : 477- 489.
  • 5Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol, 2005, 29 : 52-68.
  • 6Rankin C, Von Mehren M, Blanke C, et al. Dose effect of imatinib in patients with metastatic phase-Ⅲ Sarcoma Group Study S0033. J Clin Oncol, 2004: 9005.
  • 7Blay JY, Le Cesne AL, Ray-Coquard I, et al. Prospective muhicentric randomized phase Ⅲ study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the french sarcoma group. J Clin Oncol, 2007, 25 : 1107-1113.
  • 8Casali PG, Garrett CR, Blackstein ME, et al. Updated results from a phase III trial of sunitinib in GIST patients for whom imatinib therapy has failed due to resistance or intolerance. J Clin Oncol, 2006,24: 9513.

共引文献46

同被引文献75

  • 1董冬梅,田艳平,王延春.CEA、CA19-9和CA72-4的检测对胃肠道肿瘤的诊断价值[J].现代肿瘤医学,2006,14(2):185-186. 被引量:9
  • 2王万胜,刘斌,张家文.胃肠道间质瘤的影像学诊断[J].放射学实践,2006,21(1):48-51. 被引量:18
  • 3宋亭,沈君,郭昊昶,梁碧玲,潘恒,江魁明,冼建兴.胃肠间质瘤的影像学特征与病理学的相关性[J].中华肿瘤杂志,2007,29(5):386-390. 被引量:31
  • 4Mazur MT, Clack HB. Gastric stromal tumor reappraisal of histogenesis [J]. Am J Surg Pathol, 1983,7(6) :507-519.
  • 5Fletcher CD, Bermen JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach [J]. Human Pathol, 2002,33(5) :459 -463.
  • 6El Demellawy D, Shokry P, Ing A, et al. Polypoid gastrointestinal stromal tumor of small bowel metastasizing to mesenterie lymph nodes: a case report [J]. Pathol Res Pratt, 2008,204(3) :197 -201.
  • 7Dematteo R_P, Bellman KV, Antoneseu CR, ct al. Adjuvant imatinib mesylate after resection of loealised, primary gastrointestinal stromal tumour: a randomized, Douhle-hlind, placebo-controlled trail [ J ]. Lancet, 2009,373 (9669) : 109 - 1104.
  • 8Debie C, Rychter M, Sclot R, et al. KIT mutations and dose selection for imatinib in patients with advaced gastrointestinal stromal tumours [ J ]. Eur J Cancer, 2006,42 (8) : 1093 - 1103.
  • 9Le Cesne A, Ray-Coquard I, Bui BN, et al. Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentrc randomised phase 3 trial [ J ]. Lancet Oncol,2010,11 ( 10 ) : 942 - 949.
  • 10秦新裕,刘凤林.胃肠道间质瘤的研究进展与展望[J].中华普通外科杂志,2007,22(8):561-563. 被引量:34

引证文献15

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部